Concepedia

Xingxian Luo

XL

9

Publications

179

Citations

9

H-Index

2018

Active since

Affiliations

Peking University People's Hospital(Current)

Peking University

National Medical Products Administration

Tsinghua University

Center for Life Sciences

Xingxian Luo is an author at Peking University People's Hospital specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

2018–2024

9

Publications

9

Assessment of the Delay in Novel Anticancer Drugs between China and the United States: A Comparative Study of Drugs Approved between 2010 and 2021

Xingxian Luo, Xin Du, Zhuangqi Li et al. · Clinical Pharmacology & Therapeutics · 2022 · 33 citations

, , +22

The price, efficacy, and safety of within-class targeted anticancer medicines between domestic and imported drugs in China: a comparative analysis

Xingxian Luo, Xin Du, Lin Huang et al. · The Lancet Regional Health - Western Pacific · 2022 · 25 citations · Full text

Differential effects of C-reactive protein levels on voriconazole metabolism at three age groups in allogeneic hematopoietic cell transplant recipients

Xingxian Luo, Taifeng Li, Lei Hu et al. · Journal of Chemotherapy · 2020 · 24 citations

Evidence of pre-approval clinical trial supporting the granted conditional approval for novel cancer drugs in China between 2015 and 2022

Xingxian Luo, Xin Du, Lin Huang et al. · EClinicalMedicine · 2023 · 20 citations · Full text

The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes

Xingxian Luo, Taifeng Li, Ze Yu et al. · Xenobiotica · 2018 · 18 citations

Rows per page

1–5 of 9